Sutro Biopharma, Inc. Annual report pursuant to Section 13 and 15(d)

Statements of Stockholders Equity (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($)
Common stock, issuance costs	$ 15,686
ATM
Common stock, issuance costs	$ 777